Raskaudenkeskeytys, näytönastekatsausten kirjallisuusviitteet

Kirjallisuutta

1. Abortion care NICE guideline [NG140]Published: 25 September 2019, https://www.nice.org.uk/guidance/ng140
2. Aiken A, Lohr PA, Lord J, ym. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study. BJOG 2021;128(9):1464-1474 «PMID: 33605016»PubMed
3. Avraham S, Gat I, Duvdevani NR, ym. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study. Fertil Steril 2012;97(3):612-5 «PMID: 22265034»PubMed
4. Bernard N, Elefant E, Carlier P, ym. Continuation of pregnancy after first-trimester exposure to mifepristone: an observational prospective study. BJOG 2013;120(5):568-74 «PMID: 23346916»PubMed
5. Bracken H, Clark W, Lichtenberg ES, ym. Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol. BJOG 2011;118(1):17-23 «PMID: 21091926»PubMed
6. Bracken H, Dabash R, Tsertsvadze G, ym. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial. Contraception 2014;89(3):181-6 «PMID: 24332431»PubMed
7. Brandell K, Reynolds-Wright JJ, Boerma C, ym. Medical Abortion before Confirmed Intrauterine Pregnancy: A Systematic Review. Semin Reprod Med 2022;40(5-06):258-263 «PMID: 36626915»PubMed
8. Chan MC, Gill RK, Kim CR. Rhesus isoimmunisation in unsensitised RhD-negative individuals seeking abortion at less than 12 weeks' gestation: a systematic review. BMJ Sex Reprod Health 2022;48(3):163-168 «PMID: 34819315»PubMed
9. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. BJOG 2000;107:524-30
10. da Silva Dal Pizzol T, Knop FP, Mengue SS. Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta-analysis. Reprod Toxicol 2006;22(4):666-71 «PMID: 16750609»PubMed
11. Dal Pizzol Tda S, Sanseverino MT, Mengue SS. Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies. Cad Saude Publica 2008;24(6):1447-53 «PMID: 18545770»PubMed
12. Delgado G, Condly SJ, Davenport M, ym. A case series detailing the successful reversal of the effects of mifepristone using progesterone. Issues Law Med 2018;33(1):21-31 «PMID: 30831017»PubMed
13. Dickinson JE, Doherty DA. Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol. Contraception 2023;125():110080 «PMID: 37245784»PubMed
14. Endler M, Petro G, Gemzell Danielsson K, ym. A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial. Lancet 2022;400(10353):670-679 «PMID: 36030811»PubMed
15. Hogmark S, Liljeblad KL, Envall N, ym. Placement of an intrauterine device within 48 hours after early medical abortion-a randomized controlled trial. Am J Obstet Gynecol 2023;228(1):53.e1-53.e9 «PMID: 35970199»PubMed
16. Hognert H, Kopp Kallner H, Cameron S, ym. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hum Reprod 2016;31(11):2484-2490 «PMID: 27664217»PubMed
17. Hollenbach SJ, Cochran M, Harrington A. "Provoked" feto-maternal hemorrhage may represent insensible cell exchange in pregnancies from 6 to 22 weeks gestational age. Contraception 2019;100(2):142-146 «PMID: 30980826»PubMed
18. Horvath S, Huang ZY, Koelper NC, ym. Induced Abortion and the Risk of Rh Sensitization. JAMA 2023;330(12):1167-1174 «PMID: 37750879»PubMed
19. Horvath S, Tsao P, Huang ZY, ym. The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization. Contraception 2020;102(1):1-6 «PMID: 32135125»PubMed
20. Hsia JK, Lohr PA, Taylor J, ym. Medical abortion with mifepristone and vaginal misoprostol between 64 and 70 days' gestation. Contraception 2019;100(3):178-181 «PMID: 31102629»PubMed
21. Kemppainen V, Mentula M, Palkama V, ym. Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial. Contraception 2022;115():6-11 «PMID: 35872235»PubMed
22. Korjamo R, Mentula M, Heikinheimo O. Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial. BJOG 2017;124(13):1965-1972 «PMID: 28692170»PubMed
23. Korjamo R, Mentula M, Heikinheimo O. Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial. Contraception 2017;96(5):344-351 «PMID: 28774663»PubMed
24. Korjamo R, Mentula M, Heikinheimo O. Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1 year continuation rates: a randomised controlled trial. BJOG 2017;124(13):1957-1964 «PMID: 28650566»PubMed
25. Livshits A, Machtinger R, David LB, ym. Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study. Fertil Steril 2009;91(5):1877-80 «PMID: 18359021»PubMed
26. . Lowering the doses of mifepristone and gameprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. BJOG 2001;108(7):738-42 «PMID: 11467701»PubMed
27. Meaidi A, Friedrich S, Gerds TA, ym. Risk factors for surgical intervention of early medical abortion. Am J Obstet Gynecol 2019;220(5):478.e1-478.e15 «PMID: 30763542»PubMed
28. Meaidi A, Jasmin Friedrich S, Lidegaard Ø. Risk of surgical evacuation and risk of major surgery following second-trimester medical abortion in Denmark: A nationwide cohort study. Contraception 2020;102(3):201-206 «PMID: 32511945»PubMed
29. Nissi R, Santala M, Immonen E, ym. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination. Arch Gynecol Obstet 2016;294(6):1243-1247 «PMID: 27522599»PubMed
30. Podolskyi V, Gemzell-Danielsson K, Maltzman LL, ym. Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy. Acta Obstet Gynecol Scand 2023;102(5):541-548 «PMID: 36933004»PubMed
31. Porter Erlank C, Lord J, Church K. Acceptability of no-test medical abortion provided via telemedicine during Covid-19: analysis of patient-reported outcomes. BMJ Sex Reprod Health 2021;47(4):261-268 «PMID: 33602718»PubMed
32. Ralph LJ, Baba CF, Biggs MA, ym. Comparison of No-Test Telehealth and In-Person Medication Abortion. JAMA 2024;332(11):898-905 «PMID: 38913394»PubMed
33. Ralph LJ, Ehrenreich K, Barar R, ym. Accuracy of self-assessment of gestational duration among people seeking abortion. Am J Obstet Gynecol 2022;226(5):710.e1-710.e21 «PMID: 34922922»PubMed
34. Raymond EG, Weaver MA, Louie KS, ym. Prophylactic compared with therapeutic ibuprofen analgesia in first-trimester medical abortion: a randomized controlled trial. Obstet Gynecol 2013;122(3):558-64 «PMID: 23921857»PubMed
35. Raymond EG, Weaver MA, Tan YL, ym. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol 2016;127(2):306-12 «PMID: 26942358»PubMed
36. Reeves MF, Monmaney JA, Creinin MD. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol. Contraception 2016;93(2):119-25 «PMID: 26285178»PubMed
37. Reynolds-Wright JJ, Johnstone A, McCabe K, ym. Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic. BMJ Sex Reprod Health 2021;47(4):246-251 «PMID: 33542062»PubMed
38. Reynolds-Wright JJ, Woldetsadik MA, Morroni C, ym. Pain management for medical abortion before 14 weeks' gestation. Cochrane Database Syst Rev 2022;5(5):CD013525 «PMID: 35553047»PubMed
39. Saavedra-Avendano B, Schiavon R, Sanhueza P, ym. Early termination of pregnancy: differences in gestational age estimation using last menstrual period and ultrasound in Mexico. Reprod Health 2020;17(1):89 «PMID: 32517698»PubMed
40. Schmidt-Hansen M, Lohr PA, Cameron S, ym. Surgical or medical abortion of pregnancies between 13(+0) and 23(+6) weeks' gestation? A systematic review and new NICE national guidelines. BMJ Sex Reprod Health 2020;(): «PMID: 32184291»PubMed
41. Schmidt-Hansen M, Pandey A, Lohr PA, ym. Expulsion at home for early medical abortion: A systematic review with meta-analyses. Acta Obstet Gynecol Scand 2021;100(4):727-735 «PMID: 33063314»PubMed
42. Schonberg D, Wang LF, Bennett AH, ym. The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review. Contraception 2014;90(5):480-7 «PMID: 25152258»PubMed
43. Shochet T, Dragoman M, Blum J, ym. Could second-trimester medical abortion be offered as a day service? Assessing the feasibility of a 1-day outpatient procedure using pooled data from six clinical studies. Contraception 2019;99(5):288-292 «PMID: 30639446»PubMed
44. Tai NQR, Reynolds-Wright JJ, Cameron S. Very early medical abortion: treatment with mifepristone and misoprostol before ultrasonographic visualisation of an intrauterine pregnancy. BMJ Sex Reprod Health 2023;49(2):97-104 «PMID: 36351785»PubMed
45. . Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. BMJ 1993;307(6903):532-7 «PMID: 8400972»PubMed
46. Webster D, Penney GC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996;103(7):706-9 «PMID: 8688400»PubMed
47. Wiebe ER, Campbell M, Aiken ARA ym. Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and the Netherlands. Contraception: X 2019;1:100001
48. Wu L, Xiong W, Zeng M, ym. Different dosing intervals of mifepristone-misoprostol for second-trimester termination of pregnancy: A meta-analysis and systematic review. Int J Gynaecol Obstet 2021;154(2):195-203 «PMID: 33332580»PubMed
49. Zhang J, Zhou K, Shan D, ym. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2022;5(5):CD002855 «PMID: 35608608»PubMed